mpox
NIH Ends Study of Tecovirimat as Mpox Pain Treatment
The NIH has halted a study testing tecovirimat as a treatment for patients with mpox after the drug showed no ...
JANUARY 27, 2025
Doctor’s Lucky Shot Against Mpox
Data from a retrospective cohort study presented at CROI 2024, in Denver, suggest Tpoxx was effective in helping ...
MAY 22, 2024
Previous Smallpox Vaccination Boosts Immunogenicity of Mpox Vaccine
Immunogenicity after mpox vaccination lasted longer among people who had received a smallpox vaccination as a child ...
MAY 6, 2024
Mpox Infectious on Steel Surfaces for Up to 30 Days
Mpox virus can remain infectious on steel surfaces for up to 30 days, but is effectively inactivated by ...
JULY 25, 2023
To Prevent a Resurgence of Mpox: Vaccinate
Vaccination is still a cornerstone of the effort to end the mpox outbreak in the United States, which has resulted ...
JUNE 9, 2023
Mpox Cases Rise, Offering Reminder That Outbreak Continues
Although mpox cases have declined since, reports of continued community transmission in the United States and ...
MAY 25, 2023
CDC Releases Interim Clinical Treatment Considerations for Severe Mpox
The report mentions five severe mpox manifestations: ocular infections, neurologic complications, myopericarditis, ...
MARCH 30, 2023
Mpox Going Undiagnosed Among Homeless People
People accessing homeless services and staying in encampments may have undetected mpox infections, according to a ...
MARCH 23, 2023
Mpox Vaccine Safe and Effective in Real-World Settings
Real-world data have shown that the monkeypox (mpox) modified vaccinia Ankara vaccine (Jynneos, Bavarian Nordic) is ...
DECEMBER 29, 2022
Mpox Vaccine Safe and Effective in Real-World Settings
Real-world data have shown that the monkeypox (mpox) modified vaccinia Ankara vaccine (Jynneos, Bavarian Nordic) is ...
DECEMBER 8, 2022